Pharmaceutical compositions for use in treating pain
TW202031247A
Sustained-release pharmaceutical compositions comprising a therapeutic agent for treating diseases due to reduced bone density or cartilage loss and uses thereof
TW202033184A
Sustained-release pharmaceutical compositions comprising an immunomodulating agent and uses thereof
WO2020056102A1
Sustained-release pharmaceutical compositions comprising of a sedative drug and uses thereof
TW202023529A
Sustained-release ophthalmic pharmaceutical compositions and uses thereof
TW202011942A
Sustained-release compositions comprising a therapeutic agent for treating depression or anxiety and uses thereof
WO2020033195A1
Sustained-release pharmaceutical compositions comprising an antipsychotic drug and uses thereof
WO2020023445A1
Sustained-release pharmaceutical compositions comprising a therapeutic agent for treating dementia and uses thereof
CA3105743A1
Methods to reduce complications of intra-articular steroid
US2019321356A1
Pharmaceutical compositions of hydrophobic camptothecin derivatives
BR112020021412A2
LIPOSOMIC COMPOSITION, INHALABLE PROLONGED RELEASE FOR USE IN TREATING LUNG DISEASES
CN111432801A
Sustained release triptan compositions and methods of using same via subcutaneous or similar routes
TW201806585A
Delivery vehicle, method and kit for preparing a liposomal composition containing mild acidic agent
US2017266295A1
Controlled drug release liposome compositions and methods thereof
CA2906149A1
Controlled drug release liposome composition
US2014135357A1
Dose regime for camptothecin derivatives
KR20150048710A
Methods of treating arthritis
US2014294973A1
Pharmaceutical compositions of hydrophobic camptothecin derivatives
CA2769929A1
Ophthalmic drug delivery system containing phospholipid and cholesterol
